For Blood and Money Billionaires, Biotech, and the Quest for a Blockbuster Drug

Afbeeldingen

Artikel vergelijken

  • Engels
  • Hardcover
  • 9780393540956
  • 17 januari 2023
  • 288 pagina's
Alle productspecificaties

Samenvatting

One of Scientific American's Best Staff Reads of 2023

A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market—and save countless lives.



For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how members of the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time.

In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big.

What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.

Productspecificaties

Inhoud

Taal
en
Bindwijze
Hardcover
Oorspronkelijke releasedatum
17 januari 2023
Aantal pagina's
288

Betrokkenen

Hoofdauteur
Nathan Vardi
Hoofduitgeverij
Ww Norton & Co

Overige kenmerken

Product breedte
160 mm
Product hoogte
28 mm
Product lengte
239 mm
Studieboek
Nee
Verpakking breedte
158 mm
Verpakking hoogte
29 mm
Verpakking lengte
235 mm
Verpakkingsgewicht
896 g

EAN

EAN
9780393540956
Nog geen reviews

Kies gewenste uitvoering

Prijsinformatie en bestellen

De prijs van dit product is 19 euro en 35 cent. De meest getoonde prijs is 27 euro en 64 cent. Je bespaart 30%.
Je bespaart 30%
Op voorraad
Select
Voor 23:59 besteld, morgen in huis
Verkoop door bol
In winkelwagen
  • Gratis verzending door bol vanaf 20 euro
  • Ophalen bij een bol afhaalpunt mogelijk
  • 30 dagen bedenktijd en gratis retourneren
  • Dag en nacht klantenservice
Bezorgopties
  • Vandaag nog in huis (bestel ma-vr voor 12:00, bezorging tussen 17:00 en 22:00)
  • Doordeweeks ook ’s avonds in huis
  • Ook zondag in huis (bestel voor za 23:59)

Vaak samen gekocht

Lijst met gekozen artikelen om te vergelijken

Vergelijk artikelen